EMAIL THIS PAGE TO A FRIEND

Oftalmologia (Bucharest, Romania : 1990)

[Fixed combination of topical prostaglandin analogue in glaucoma treatment].


PMID 22428296

Abstract

The purpose of glaucoma treatment is to prevent progressive loss of optic nerve fibers and thereby to preserve the visual field. Because increased IOP is a primary risk factor in developing glaucoma, descrease its value below which may affect the optic is the antiglaucoma treatment target. This paper provides an overview of glaucoma treatment and the use of fixed combinations of topical prostaglandin analogues (PGA).

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SML0216
Brinzolamide, ≥98% (HPLC)
C12H21N3O5S3